Moderna Covid Vaccine Has Higher Heart Risk for Young Men Than Pfizer Shot

Moderna’s COVID-19 (CCP Virus) vaccine may have a higher risk of heart inflammation in young men than the Pfizer/BioNtech shot, according to data presented to U.S. Food and Drug Administration (FDA) advisers on Tuesday, Reuters reported on June 14.

According to data from a US Centers for Disease Control and Prevention database, there were 4.41 cases of heart inflammation per 100,000 people aged 18-39 years who received the Pfizer/BioNtech injection, versus 6.27 cases per 100,000 people for Modena.

A comparison of the two showed that young men aged 18-39 years had a 1.1 to 1.5 times higher risk of myocarditis and pericarditis after the Modena shot.

Some European countries have limited use of the Covid vaccine in younger populations after surveillance suggested it was linked to a higher risk of cardiac inflammation, and the FDA delayed its review of the Modena vaccine to assess the myocarditis risk.

U.S. experts are considering these data before deciding whether to recommend Modena’s vaccine for children and teens ages 6-17, while Pfizer’s vaccine is already authorized for children ages 5 and older.In response, netizens commented that data have shown that both the Pfizer and Modena vaccines put the vaccine recipients at excessive risk of heart inflammation. More importantly, without digging out the true source of the CCP virus, any assessment review in the United States is not rigorous and is contrary to the “science.” Under these circumstances, any mandatory vaccination is irresponsible and is “murder.”